Sadia Rahman
Stock Analyst at Wells Fargo
(1.33)
# 3,550
Out of 5,182 analysts
3
Total ratings
66.67%
Success rate
-5.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sadia Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Initiates: Overweight | $30 | $18.05 | +66.20% | 1 | Mar 19, 2026 | |
| DNTH Dianthus Therapeutics | Initiates: Overweight | $135 | $86.00 | +56.98% | 1 | Mar 19, 2026 | |
| MAZE Maze Therapeutics | Initiates: Overweight | $55 | $28.71 | +91.57% | 1 | Dec 4, 2025 |
Vor Biopharma
Mar 19, 2026
Initiates: Overweight
Price Target: $30
Current: $18.05
Upside: +66.20%
Dianthus Therapeutics
Mar 19, 2026
Initiates: Overweight
Price Target: $135
Current: $86.00
Upside: +56.98%
Maze Therapeutics
Dec 4, 2025
Initiates: Overweight
Price Target: $55
Current: $28.71
Upside: +91.57%